Lack of correlation between iron overload cardiac dysfunction and needle liver biopsy iron concentration

Haematologica

Volumn 90, Issue 5, 2005, Pages 685-686

  Berdoukas, Vasili ^a,d   Dakin, Carolyn ^a   Freeman, Anthony ^b   Fraser, Ian ^a   Aessopos, Athanassios ^c   Bohane, Timothy ^a  

^a SYDNEY CHILDREN'S HOSPITAL   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

^c UNIVERSITY OF ATHENS   (Greece)

^d AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

Author keywords

Cardiac dysfunction; Iron overload; Liver iron concentration; Thalassemia

Indexed keywords

IRON;

ADOLESCENT; ADULT; ANEMIA; ARTICLE; BLOOD TRANSFUSION; CORRELATION ANALYSIS; ECHOCARDIOGRAPHY; EXERCISE; HEART DEATH; HEART DISEASE; HEART FUNCTION; HUMAN; IRON OVERLOAD; LIVER BIOPSY; LIVER LEVEL; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; RISK ASSESSMENT; SCHOOL CHILD;

ADOLESCENT; ADULT; ANEMIA, DIAMOND-BLACKFAN; ANEMIA, SICKLE CELL; BIOLOGICAL MARKERS; BIOPSY, NEEDLE; BLOOD TRANSFUSION; CHILD; FEMALE; GATED BLOOD-POOL IMAGING; HEART DISEASES; HUMANS; IRON; IRON OVERLOAD; LIVER; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; THALASSEMIA;

EID: 20344381825     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Angelucci E, Brittenham GM, McLaren CE, Ripalti M, Baronciani D, Giardini C, et al. Hepatic iron concentration and total body iron stores in thalassaemia major. N Engl J Med 2000;343:327-31.
2. Brittenham GM, Griffith PM, Nienhuis AW, McLAren CE, Young NS, Tucker EE, et al. Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major. N Engl J Med 1994;331:567-73.
3. Olivieri NF, Brittenham GM. Iron-chelating therapy and the treatment of thalassemia Blood 1997;89:739-61.
4. Leon MB, Borer JS, Bacharach SL, Green MV, Benz EJ Jr, Griffith P, et al. Detection of early cardiac dysfunction in patients with severe β-thalassemia and chronic iron overload. N Engl J Med 1979;301:1143-8.
5. Freeman AP, Giles RW, Berdoukas VA, Walsh WF, Choy D, Murray PC. Early left ventricular dysfunction and chelation therapy in thalassaemia major. Ann Int Med 1983;99:450-4.
6. Freeman AP, Giles RW, Berdoukas VA, Talley P and Murray PC. Sustained normalization of cardiac function by chelation therapy in thalassaemia major. Clin Lab Haematol 1989;11:299-307.
7. Berdoukas V, Bohane T, Tobias V, De Silva K, Fraser I, Aessopos A, et al. Liver iron concentration and fibrosis in a cohort of transfusion-dependent patients on long-term desferrioxamine therapy. Eur Hem J 2005;5:572-8.
8. Anderson LJ, Wonke B, Prescott E, Holden S, Walker JM, Pennell DJ. Comparison and effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in β-thalassaemia. Lancet 2002;360:516
9. Anderson LJ, Holden S, Davis B, Prescott E, Charrier CC, Bunce NH, et al. Cardiovascular T2* magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001;22:2171-9.
10. Wood JC, Tyszka M, Carson S, Nelson M, Coates T, Myocardial iron loading in transfusion-dependent thalassemia and sickle-cell disease. Blood 2003;20:103-5.